241. Hypertyrosinemia type I Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 14 / Drugs : 7 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 5
| Previous names | - | ||
|---|---|---|---|
| Other names | Tyrosinemia type I;Tyrosinemia I;Hereditary tyrosinemia, Type I;Fumarylacetoacetate hydrolase deficiency;FAH deficiency; | ||
| Disease group | Metabolic diseases | ||
| Related info (in Japanese) | - | ||
| Designated intractable diseases (in Japanese) | Overview, Diagnostic criteria, etc. (docx), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 8-1-2. Tyrosinemia type 1 | ||
| Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 241-1. | Acute hypertyrosinemia type I;Acute tyrosinemia type I;Acute tyrosinemia I; | 8-1-2. Tyrosinemia type 1 | |
| 241-2. | Subacute hypertyrosinemia type I;Subacute tyrosinemia type I;Subacute tyrosinemia I; | 8-1-2. Tyrosinemia type 1 | |
| 241-3. | Chronic hypertyrosinemia type I;Chronic tyrosinemia type I;Chronic tyrosinemia I; | 8-1-2. Tyrosinemia type 1 | |